CD274 and neoplasm: The goal of PD-1/PD-L1 ICIs is to block the interaction between PD-1 and PD-L1 to inhibit PD-1 signaling, reverse T cell exhaustion, and re-activate anti-tumor immune responses to promote tumor regression.